Dyslipidemia Drug Indications

Dyslipidemia Drug Indications

DYSLIPIDEMIA DRUG INDICATIONS
Generic Brand Form Indications
Slow
coronary
athero-
sclerosis
Lower
total-C
Lower
LDL-C
Increase
HDL-C
Lower
apo B
Lower
TG
Sitosterol/
campe-
sterol
Reduce
risk of
CVD4
ADENOSINE TRIPHOSPHATE-CITRATE LYASE (ACL) INHIBITOR + CHOLESTEROL ABSORPTION INHIBITOR
bempedoic acid + ezetimibe Nexlizet tabs ✓ ✓ ✓    
ANGIOPOIETIN-LIKE 3 (ANGPTL3) INHIBITOR
evinacumab-dgnb Evkeeza IV inj ✓ ✓ ✓ ✓
BILE ACID SEQUESTRANTS
cholestyr–
amine resin
— pwd ✓   ✓
colesevelam Welchol tabs,
oral susp
✓
colestipol Colestid tabs,
granules
✓ ✓
CHOLESTEROL ABSORPTION INHIBITOR
ezetimibe Zetia tabs ✓ ✓ ✓ ✓2
FIBRATES
fenofibrate Antara caps ✓ ✓ ✓ ✓ ✓
Fenoglide tabs ✓ ✓ ✓ ✓ ✓
Lipofen caps ✓ ✓ ✓ ✓ ✓
Tricor tabs ✓ ✓ ✓ ✓ ✓
Triglide tabs ✓ ✓ ✓ ✓ ✓
fenofibric acid Trilipix del-rel caps ✓ ✓ ✓ ✓ ✓
LIPID-REGULATING AGENT
gemfibrozil Lopid scored tabs ✓1 ✓ ✓
icosapent ethyl Vascepa caps ✓ ✓
omega-3-acid
ethyl esters
Lovaza caps ✓
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) INHIBITOR
lomitapide mesylate Juxtapid caps ✓ ✓3 ✓
NICOTINIC ACID DERIVATIVES
niacin — ext-rel tabs ✓ ✓ ✓ ✓ ✓ ✓ ✓
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITOR
alirocumab Praluent SC inj ✓ ✓ ✓ ✓
evolocumab Repatha SC inj ✓ ✓ ✓ ✓
Repatha Pushtronex SC inj ✓ ✓ ✓ ✓
SMALL INTERFERING RNA (siRNA)
inclisiran Leqvio SC inj ✓ ✓   ✓    
STATINS (HMG-CoA REDUCTASE INHIBITORS)
atorvastatin Atorvaliq oral susp ✓ ✓ ✓ ✓ ✓ ✓
Lipitor tabs ✓ ✓ ✓ ✓ ✓ ✓
fluvastatin — caps ✓ ✓ ✓ ✓ ✓ ✓ ✓
Lescol XL ext-rel tabs ✓ ✓ ✓ ✓ ✓ ✓ ✓
lovastatin — tabs ✓ ✓ ✓ ✓ ✓ ✓
Altoprev ext-rel tabs ✓ ✓ ✓ ✓ ✓ ✓ ✓
pitavastatin Livalo tabs ✓ ✓ ✓ ✓ ✓
Zypitamag tabs ✓ ✓ ✓ ✓ ✓
pravastatin — tabs ✓ ✓ ✓ ✓ ✓ ✓ ✓
rosuvastatin Crestor tabs ✓ ✓ ✓3 ✓ ✓ ✓ ✓
Ezallor Sprinkle caps ✓ ✓ ✓ ✓ ✓  
simvastatin Zocor tabs ✓ ✓ ✓ ✓ ✓ ✓
STATIN + CALCIUM CHANNEL BLOCKER
atorvastatin +
amlodipine
Caduet tabs ✓ ✓ ✓ ✓ ✓ ✓
STATIN + CHOLESTEROL ABSORPTION INHIBITOR
simvastatin +
ezetimibe
Vytorin tabs ✓ ✓ ✓ ✓ ✓
NOTES

Key:  apo B = apolipoprotein B; TG = triglycerides; total-C = total cholesterol; LDL-C = low-density lipoproteins; CVD = cardiovascular disease; IDL = intermediate-density lipoproteins; VLDL = very low density lipoproteins; HDL-C = high-density lipoproteins

1 Reduction in risk of coronary artery disease when first line agent is inadequate

2 To reduce elevated sitosterol and campesterol in homozygous familial sitosterolemia

3 Also to reduce elevated non-HDL-C (total-C minus HDL-C)

4 To reduce risk of: MI, stroke, or coronary revascularization procedures, and morbidity/mortality.

 

Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.
Listed indications may be adjuncts to other therapies, lifestyle changes and/or concomitant drugs.

(Rev. 9/2023)